Thailand Warns Against Popular Hong Thai Inhalers Over Health Risks
The **Thai Food and Drug Administration** has recalled a batch of popular **Hong Thai Herbal** inhalers after they failed health quality tests due to contaminat
Summary
The **Thai Food and Drug Administration** has recalled a batch of popular **Hong Thai Herbal** inhalers after they failed health quality tests due to contamination. The products, known as **yadom** in the Thai language, are portable aromatherapy inhalers widely used in several parts of **Southeast Asia** for nasal congestion, dizziness, and motion sickness. The affected batch was manufactured in **December last year** with an expiry date of **2027**. **Hong Thai Herbal** has pledged full refunds to any customers or partners who still have stocks of the contaminated batch. The company's products have been popularized by celebrities like **BLACKPINK's Lisa**, **Chris Hemsworth**, and **Central Cee**. The inhalers contain ingredients like **camphor**, **menthol**, and **eucalyptus oil**, which provide temporary relief and a refreshing sensation. However, overuse can lead to serious side effects, including negative effects from too much **menthol** inhalation. Doctors advise using inhalers no more than **three times daily** and consulting a healthcare professional if symptoms persist.
Key Takeaways
- The Thai Food and Drug Administration has recalled a batch of Hong Thai Herbal inhalers due to contamination
- The affected batch was manufactured in December last year with an expiry date of 2027
- Hong Thai Herbal has pledged full refunds to any customers or partners who still have stocks of the contaminated batch
- The incident highlights the need for stricter regulations on herbal products in Southeast Asia
- Consumers should be aware of the potential risks associated with herbal products and use them responsibly
Balanced Perspective
The recall of the **Hong Thai Herbal** inhalers is a reminder that even popular and widely used products can pose health risks if not manufactured and regulated properly. The incident highlights the need for rigorous testing and quality control measures to ensure the safety of consumers. While **Hong Thai Herbal** has taken steps to address the issue, it is essential for users to be aware of the potential risks associated with **herbal inhalers** and to use them responsibly. The incident also raises questions about the regulation of **herbal products** in **Southeast Asia** and the need for more stringent standards. [[southeast-asia|Southeast Asia]] has a large market for herbal products, and regulatory bodies must be vigilant.
Optimistic View
The recall of the contaminated **Hong Thai Herbal** inhalers demonstrates the effectiveness of **Thailand's FDA** in ensuring public health and safety. The company's prompt response and commitment to refunds also show a responsible approach to the issue. With proper use and guidance, **herbal inhalers** can still provide relief for users. The incident may also lead to increased awareness about the potential risks of overusing inhalers and the importance of following instructions. [[thailand-fda|Thailand's FDA]] has set a good example for other regulatory bodies in the region.
Critical View
The contamination of **Hong Thai Herbal** inhalers is a concerning issue that highlights the potential risks associated with **herbal products**. The fact that the products were widely used and popularized by celebrities may have contributed to their widespread use, potentially putting more people at risk. The recall may not be enough to mitigate the damage, and users who have already been exposed to the contaminated products may still experience adverse effects. The incident also raises questions about the effectiveness of regulatory bodies in **Thailand** and **Southeast Asia** in ensuring the safety of consumers. [[herbal-products|Herbal products]] can be risky if not properly regulated.
Source
Originally reported by Times Now